Strainprint Wants to Change the Limitations of Medical Cannabis Research

The use of cannabis as a medical tool for patients in Canada has expanded greatly thanks to the advancements of the policy implemented by the federal government as it seeks full legalization of the drug. More and more patients are looking into the potential of cannabis as a legitimate tool for combating several diseases.

With a clearer path towards medical use, data and tests are crucial for the development of cannabis in this industry–an area where the market has been severely lacking. A software company in Toronto is trying to change the shortage of data available to the whole industry.

Read full article here

Strainprint™ Technologies Ltd. (“Strainprint”) Expands Nationwide Coverage With the Addition of Harvest Medicine to The Strainprint Community


Toronto, August 2, 2017 – Strainprint, the leader in cannabis data collection and strain efficacy reporting [analytics], is pleased to welcome Harvest Medicine cannabis clinic to its growing list of data customers. Based in Calgary, Alberta, Harvest Medicine (“Harvest”) is a world-class medical cannabis clinic with a focus on education and 360-degree patient wellness. Their state-of-the art educational resource centre hosts events, workshops to help create a sense of community for medical cannabis patients and those who love and support them in their health goals.

“In our search for resources to better serve our patients, we found Strainprint to have the most comprehensive and granular source of strain efficacy data. We will use this data to validate our existing knowledge base and to help shape our education initiatives,” said the CEO of Harvest Medicine. “Plus, the simple interface, breadth of symptom and strain coverage and ease of reporting make the Strainprint app the perfect value-add companion tool for our passionate patients.”

Harvest will begin promoting the Strainprint app to its 5,000+ cannabis patients immediately through a unique activation code. Patients are encouraged to log their medication sessions to track which strains work best for their symptoms. On each clinic visit patients share their detailed outcomes reports with their doctor and together determine optimal treatment for overall wellness.

“We are so excited to work with the Harvest team to develop education programs and to help optimize our web-based clinical analytics platform. From the first moment we met the Harvest team, we could see their forward-thinking, fact-based approach to patient care. We’re here to support them,” said Strainprint C.E.O., Andrew Muroff.

The Strainprint App can be downloaded from both the iOS App Store and GooglePlay Store.

About StrainprintTM:
Founded in Toronto in 2016, StrainprintTM Technologies Ltd. is a Toronto-based software company providing enterprise grade analytics and consumer solutions for the medical cannabis industry. Strainprint manages the gathering and analysis of real-time cannabis consumption data and ranks specific strain efficacy against conditions and related symptoms. StrainprintTM data supports cannabis researchers globally and provides advanced intelligence to licensed producers to optimize grow operations and to clinics to improve treatment recommendations. For more information visit, facebook, twitter, linkedin

Media Contact:
Jessica Moran
StrainprintTM Technologies Ltd.

Strainprint™ Technologies Ltd. (Strainprint) Closes Private Investment Round and Releases Major Product Update

Revolutionary Medical Cannabis Tracking APP Solidifies Global Lead in Providing Patient and Medical Community Data and Analytics

TORONTO, May 31, 2017 /CNW/ – Strainprint, the leader in cannabis patient and strain efficacy data, is pleased to announce that it has recently closed a private investment round. The Company plans to use proceeds to aggressively build brand and presence in legal North American markets through education and awareness campaigns. This investment will also allow accelerated delivery of Strainprint’s advanced analytic solutions for clinical and research environments. “Our investors understand that demand-side, patient efficacy data is sorely lacking and see Strainprint as the best solution available to meet the industry’s needs,” said Strainprint CEO, Andrew Muroff.

The latest release of the Strainprint mobile app, found here, was recently launched at Lift Expo 2017. The new release significantly simplifies the patient profile-creation experience and broadly expands the medical database to track over 300 conditions and over 30 associated symptoms.  “I’m honoured and proud of the incredible solution that we’ve brought to market.  In the weeks since public launch, Strainprint has already helped thousands of patients across Canada and the U.S. to track their cannabis medication outcomes and learn what works best for them,” said Stephanie Karasick, CSO and visionary behind the Strainprint app.

Over the coming weeks and months, Strainprint will be announcing participation in a variety of ground breaking cannabis studies with strategic partners in Canada, the United States and other legal markets.

About Strainprint™:
Founded in 2016, Strainprint™ Technologies Ltd. is a Toronto-based software company providing enterprise grade analytics and consumer solutions for the medical cannabis industry.  Strainprint™ manages the gathering and analysis of real-time cannabis consumption data and ranks specific strain efficacy against conditions and related symptoms. Strainprint™ also works with commercial producers and clinics to provide advanced intelligence to optimize grow operations and advance treatment recommendations.  For more information visit facebook, twitter, linkedin


For further information:

Media Contact: Jessica Moran, Strainprint™ Technologies Ltd., 519-312-1365,

Lift News Article: 3 Canadian moms open up about cannabis


Two members of the Strainprint team were profiled in Lift News for Mother’s Day. The article highlights 3 Candian moms who open up about their medical cannabis journeys. Have a look at the full article to learn more about moms and cannabis: